Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 210-216

  Fang, Zhiqing ^a   Tang, Yueqing ^a   Jiao, Wei ^a   Xing, Zhaoquan ^a   Guo, Zhaoxin ^a   Wang, Weichang ^a   Xu, Zhonghua ^a   Liu, Zhaoxu ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; ERK; Nitidine chloride; Renal cancer

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITIDINE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; BENZOPHENANTHRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIDNEY CANCER; MALE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; KIDNEY TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BENZOPHENANTHRIDINES; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, NUDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896704058     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.049     Document Type: Article

References (45)

1. Antonsson B. Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res. 2001, 306:347-361.
2. Baffy G., Miyashita T., Williamson J.R., Reed J.C. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 1993, 268:6511-6519.
3. Balmanno K., Cook S.J. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 2009, 16:368-377.
4. Chan S.L., Yu V.C. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin. Exp. Pharm. Physiol. 2004, 31:119-128.
5. Chen J., Wang J., Lin L., He L., Wu Y., Zhang L., Yi Z., Chen Y., Pang X., Liu M. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol. Cancer Therap. 2012, 11:277-287.
6. Chou Y.H., Ho Y.S., Wu C.C., Chai C.Y., Chen S.C., Lee C.H., Tsai P.S., Wu C.H. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation. Food Chem. Toxicol. 2007, 45:1356-1367.
7. Costa L.J., Drabkin H.A. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. The Oncologist 2007, 12:1404-1415.
8. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr. Opin. Cell Biol. 2000, 12:414-419.
9. Cushman M., Mohan P., Smith E.C. Synthesis and biological activity of structural analogues of the anticancer benzophenanthridine alkaloid nitidine chloride. J. Med. Chem. 1984, 27:544-547.
10. Del Poeta M., Chen S.F., Von Hoff D., Dykstra C.C., Wani M.C., Manikumar G., Heitman J., Wall M.E., Perfect J.R. Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob. Agents Chemother. 1999, 43:2862-2868.
11. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., Elledge S.J., Reed S.I. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994, 76:1013-1023.
12. Escudier B., Eisen T., Stadler W.M., Szczylik C., Oudard S., Staehler M., Negrier S., Chevreau C., Desai A.A., Rolland F., Demkow T., Hutson T.E., Gore M., Anderson S., Hofilena G., Shan M., Pena C., Lathia C., Bukowski R.M. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J. Clin. Oncol. 2009, 27:3312-3318.
13. Fan Y.J., Zhou J., Li M. Effect of nitidine chloride on the life cycle of Ehrlich ascites carcinoma cells in mice (author's transl). Zhongguo yao li xue bao = Acta Pharmacol. Sinica 1981, 2:46-49.
14. Fang Z., Tang Y., Jiao W., Xing Z., Guo Z., Wang W., Shi B., Xu Z., Liu Z. Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food Chem. Toxicol. 2013, 60:246-251.
15. Gendron S., Couture J., Aoudjit F. Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J. Biol. Chem. 2003, 278:48633-48643.
16. Gupta K., Miller J.D., Li J.Z., Russell M.W., Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat. Rev. 2008, 34:193-205.
17. Habibovic S., Hrgovic Z., Bukvic I., Hrgovic I. Molecular mechanisms in apoptosis. Medicinski Arhiv 2000, 54:33-40.
18. Hennet T., Bertoni G., Richter C., Peterhans E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 1993, 53:1456-1460.
19. Herrmann E., Bierer S., Wulfing C. Update on systemic therapies of metastatic renal cell carcinoma. World J. Urol. 2010, 28:303-309.
20. Hu J., Zhang W.D., Liu R.H., Zhang C., Shen Y.H., Li H.L., Liang M.J., Xu X.K. Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities. Chem. Biodiver. 2006, 3:990-995.
21. Inman B.A., Harrison M.R., George D.J. Novel immunotherapeutic strategies in development for renal cell carcinoma. Eur. Urol. 2013, 63:881-889.
22. Janzen N.K., Kim H.L., Figlin R.A., Belldegrun A.S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North America 2003, 30:843-852.
23. 2+ fluxes. Proc. Natl. Acad. Sci. USA 1994, 91:6569-6573.
24. Li C., Chi S., He N., Zhang X., Guicherit O., Wagner R., Tyring S., Xie J. IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. Oncogene 2004, 23:1608-1617.
25. Lin M.W., Lin A.S., Wu D.C., Wang S.S., Chang F.R., Wu Y.C., Huang Y.B. Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis. Food Chem. Toxicol. 2012, 50:4333-4339.
26. Ljungberg B., Cowan N.C., Hanbury D.C., Hora M., Kuczyk M.A., Merseburger A.S., Patard J.J., Mulders P.F., Sinescu I.C. EAU guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 2010, 58:398-406.
27. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L., Prevost M.C., Xie Z., Matsuyama S., Reed J.C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998, 281:2027-2031.
28. McCubrey J.A., Steelman L.S., Abrams S.L., Lee J.T., Chang F., Bertrand F.E., Navolanic P.M., Terrian D.M., Franklin R.A., D'Assoro A.B., Salisbury J.L., Mazzarino M.C., Stivala F., Libra M. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv. Enzyme Regul. 2006, 46:249-279.
29. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
30. Pan X., Han H., Wang L., Yang L., Li R., Li Z., Liu J., Zhao Q., Qian M., Liu M., Du B. Nitidine chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway. Cancer Lett. 2011, 313:181-191.
31. Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310.
32. Scherr A.J., Lima J.P., Sasse E.C., Lima C.S., Sasse A.D. Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis. BMC Cancer 2011, 11:115.
33. Schrader A.J., Hofmann R. Metastatic renal cell carcinoma: recent advances and current therapeutic options. Anti-cancer Drugs 2008, 19:235-245.
34. Shelton J.G., Steelman L.S., White E.R., McCubrey J.A. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells. Cell Cycle 2004, 3:372-379.
35. Somanath P.R., Kandel E.S., Hay N., Byzova T.V. Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J. Biol. Chem. 2007, 282:22964-22976.
36. Somanath P.R., Vijai J., Kichina J.V., Byzova T., Kandel E.S. The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene 2009, 28:2365-2369.
37. Tan G.T., Lee S., Lee I.S., Chen J., Leitner P., Besterman J.M., Kinghorn A.D., Pezzuto J.M. Natural-product inhibitors of human DNA ligase I. Biochem. J. 1996, 314(Pt 3):993-1000.
38. Thillai K., Allan S., Powles T., Rudman S., Chowdhury S. Neoadjuvant and adjuvant treatment of renal cell carcinoma. Expert Rev. Anticancer Ther. 2012, 12:765-776.
39. Thompson N., Lyons J. Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr. Opin. Pharmacol. 2005, 5:350-356.
40. Xing Z., Zhou Z., Yu R., Li S., Li C., Nilsson S., Liu Z. XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells. J. Exp. Clin. Cancer Res.: CR 2010, 29:162.
41. Yang J.S., Lin C.W., Hsieh Y.S., Cheng H.L., Lue K.H., Yang S.F., Lu K.H. Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways. Food Chem. Toxicol. 2013, 59:801-807.
42. Yu Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist. Updat. 2006, 9:19-25.
43. Zelivianski S., Spellman M., Kellerman M., Kakitelashvilli V., Zhou X.W., Lugo E., Lee M.S., Taylor R., Davis T.L., Hauke R., Lin M.F. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int. J. Cancer 2003, 107:478-485.
44. Zhang N., Kong X., Yan S., Yuan C., Yang Q. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci. 2010, 101:2375-2383.
45. Zhang N., Wang X., Huo Q., Li X., Wang H., Schneider P., Hu G., Yang Q. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer. J. Biol. Chem. 2013, 288:9396-9407.